OKYO 6-K: SEC filing
OKYO Pharma
Filed with the SEC on · accession 0001493152-26-050047
OKYO filed a 6-K (foreign company report) with the SEC on Nov 5, 2026. OKYO Pharma announced that CEO Robert J. Dempsey will present at the Stifel 2026 Healthcare Conference on November 12, 2026, with leadership available for one-on-one investor meetings.
Summary of the filing
OKYO Pharma announced that CEO Robert J. Dempsey will present at the Stifel 2026 Healthcare Conference on November 12, 2026, with leadership available for one-on-one investor meetings. The company also noted its lead candidate urcosimod recently enrolled the first patients in the Phase 3 NEPTUNE trial.
Key details
✦ Ask GOAX AI about this filing — what it means for OKYO, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for OKYO?
Click hereFrequently asked questions
What did OKYO file with the SEC on Nov 5, 2026?
OKYO filed a 6-K (SEC filing). OKYO Pharma announced that CEO Robert J. Dempsey will present at the Stifel 2026 Healthcare Conference on November 12, 2026, with leadership available for one-on-one investor meetings. The company also noted its lead candidate urcosimod recently enrolled the first patients in the Phase 3 NEPTUNE trial.
How do I read a 6-K?
How foreign companies listed in the US report news and events — like an 8-K for them. Look at the exhibit names: "results", "resign", "notice" tell you the topic. Many 6-Ks are routine (meeting notices); results and leadership changes matter most.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 6-K (foreign company report): How foreign companies listed in the US report news and events — like an 8-K for them.
Other OKYO SEC filings
- 6-K · SEC filingOct 6, 2026
- 6-K · SEC filingSep 29, 2026
- 6-K · SEC filingSep 9, 2026
- 6-K · SEC filingSep 8, 2026
- 20-F · SEC filingAug 7, 2026
- 6-K · Insider sale plannedJul 28, 2026
- 6-K · SEC filingJul 27, 2026
- 6-K · Insider sale plannedJul 23, 2026
- 6-K · Insider sale plannedJul 23, 2026
- 6-K · Insider sale plannedJul 22, 2026
Get alerts when OKYO files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days